8-K
filed June 15, 2023, 7:59 PM ET
ticker IRMD
CIK 0001325618
other material
confidence high
sentiment neutral
materiality 0.15
Iradimed shareholders elect all five director nominees, approve equity plan and charter amendment
IRADIMED CORP
- Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel, James Hawkins elected to board (vote ranges: 7.9M-10.9M for).
- Ratified RSM US LLP as auditor for FY2023 (11,617,623 for, 8,816 against).
- Advisory say-on-pay approved (10,782,715 for, 133,595 against).
- Approved 2023 Equity Incentive Plan (8,665,347 for, 2,251,481 against).
- Approved charter amendment limiting officer liability (10,139,697 for, 779,087 against).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IRADIMED CORP shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation at the 2023-06-15 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
Stockholders voted, on an advisory basis, on the frequency of future advisory votes on executive compensation.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IRADIMED CORP shareholders approved Advisory resolution on the compensation of Iradimed's named executive officers at the 2023-06-15 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
Stockholders approved an advisory resolution on the compensation of Iradimed's named executive officers.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IRADIMED CORP shareholders approved Election of Directors at the 2023-06-15 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
Stockholders elected each of Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earlier, such director's removal or resignation from our Board), as set forth below.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IRADIMED CORP shareholders approved Amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company at the 2023-06-15 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
Stockholders approved an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IRADIMED CORP shareholders approved Approval of the Iradimed Corporation 2023 Equity Incentive Plan at the 2023-06-15 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
Stockholders approved the Iradimed Corporation 2023 Equity Incentive Plan.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IRADIMED CORP shareholders approved Ratification of the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-15
Exact text from the filing
Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2023, as set forth below.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.